The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial
Keyword(s):
Keyword(s):
2015 ◽
Vol 21
(5)
◽
pp. 471-476
◽
Keyword(s):
COMT Val158Met polymorphism and Parkinson’s disease risk: a pooled analysis in different populations
2019 ◽
Vol 41
(4)
◽
pp. 319-325
◽